Correction: Proteasome dysfunction mediates high glucose-induced apoptosis in rodent beta cells and human islets PLoS ONE (2014) 9, 3 (e92066) DOI: 10.1371/journal.pone.0092066;Proteasome dysfunction mediates high glucose-induced apoptosis in rodent beta cells and human islets

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Broca, Christophe ^a,b   Varin, Elodie ^a,b   Armanet, Mathieu ^b   Tourrel Cuzin, Cécile ^c   Bosco, Domenico ^d   Dalle, Stéphane ^a,b   Wojtusciszyn, Anne ^a,b,e  

^a UNIV MONTPELLIER   (France)

^b HÔPITAL SAINT ELOI   (France)

^c Groupe Hospitalier Pitié Salpêtrière   (France)

^d UNIVERSITY OF GENEVA   (Switzerland)

^e LAPEYRONIE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; DNA FRAGMENT; EXENDIN 4; GLUCOSE; HISTONE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEASOME; UBIQUITIN; ANTIDIABETIC AGENT; DDIT3 PROTEIN, HUMAN; DDIT3 PROTEIN, RAT; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; PEPTIDE; PROTEASOME INHIBITOR; VENOM;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL DEATH; CELL FUNCTION; CELL SURVIVAL; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; GLUCOTOXICITY INDUCED APOPTOSIS; HUMAN; HYPERGLYCEMIA; IMMUNOBLOTTING; IN VITRO STUDY; MALE; NONHUMAN; PANCREAS ISLET BETA CELL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING; ANIMAL; CELL CULTURE; DRUG EFFECTS; GENE EXPRESSION; GENETICS; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CASPASE 3; CELLS, CULTURED; ENDOPLASMIC RETICULUM STRESS; GENE EXPRESSION; GLUCOSE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN-SECRETING CELLS; MALE; PEPTIDES; POLY(ADP-RIBOSE) POLYMERASES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEASOME INHIBITORS; PROTEOLYSIS; RATS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR CHOP; UBIQUITIN; VENOMS;

EID: 84898622141     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0102652     Document Type: Erratum

References (49)

1. Weir GC, Marselli L, Marchetti P, Katsuta H, Jung MH, et al. (2009) Towards better understanding of the contributions of overwork and glucotoxicity to the beta-cell inadequacy of type 2 diabetes. Diabetes Obes Metab 11 Suppl 4: 82-90.
2. Jonas JC, Bensellam M, Duprez J, Elouil H, Guiot Y, et al. (2009) Glucose regulation of islet stress responses and beta-cell failure in type 2 diabetes. Diabetes Obes Metab 11 Suppl 4: 65-81.
3. Robertson RP, Harmon J, Tran PO, Poitout V (2004) Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes 53 Suppl 1: S119-124. (Pubitemid 38168703)
4. Goldberg AL (2003) Protein degradation and protection against misfolded or damaged proteins. Nature 426: 895-899. (Pubitemid 38056882)
5. Ciechanover A (2005) Proteolysis: from the lysosome to ubiquitin and the proteasome. Nat Rev Mol Cell Biol 6: 79-87.
6. Coux O, Tanaka K, Goldberg AL (1996) Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem 65: 801-847. (Pubitemid 26255262)
7. Yan FF, Lin CW, Cartier EA, Shyng SL (2005) Role of ubiquitin-proteasome degradation pathway in biogenesis efficiency of {beta}-cell ATP-sensitive potassium channels. Am J Physiol Cell Physiol 289: C1351-1359. (Pubitemid 41456852)
8. Kawaguchi M, Minami K, Nagashima K, Seino S (2006) Essential role of ubiquitin-proteasome system in normal regulation of insulin secretion. J Biol Chem 281: 13015-13020. (Pubitemid 43855210)
9. Kitiphongspattana K, Mathews CE, Leiter EH, Gaskins HR (2005) Proteasome inhibition alters glucose-stimulated (pro)insulin secretion and turnover in pancreatic {beta}-cells. J Biol Chem 280: 15727-15734. (Pubitemid 40616692)
10. Hartley T, Brumell J, Volchuk A (2009) Emerging roles for the ubiquitinproteasome system and autophagy in pancreatic beta-cells. Am J Physiol Endocrinol Metab 296: E1-10.
11. Lopez-Avalos MD, Duvivier-Kali VF, Xu G, Bonner-Weir S, Sharma A, et al. (2006) Evidence for a role of the ubiquitin-proteasome pathway in pancreatic islets. Diabetes 55: 1223-1231. (Pubitemid 44195358)
12. Kalbe L, Leunda A, Sparre T, Meulemans C, Ahn MT, et al. (2005) Nutritional regulation of proteases involved in fetal rat insulin secretion and islet cell proliferation. Br J Nutr 93: 309-316.
13. Storling J, Allaman-Pillet N, Karlsen AE, Billestrup N, Bonny C, et al. (2005) Antitumorigenic effect of proteasome inhibitors on insulinoma cells. Endocrinology 146: 1718-1726. (Pubitemid 40396880)
14. Wojcik C (1999) Proteasomes in apoptosis: villains or guardians? Cell Mol Life Sci 56: 908-917. (Pubitemid 30019210)
15. Costes S, Vandewalle B, Tourrel-Cuzin C, Broca C, Linck N, et al. (2009) Degradation of cAMP-responsive element-binding protein by the ubiquitinproteasome pathway contributes to glucotoxicity in beta-cells and human pancreatic islets. Diabetes 58: 1105-1115.
16. Broemer M, Meier P (2009) Ubiquitin-mediated regulation of apoptosis. Trends Cell Biol 19: 130-140.
17. Casas S, Gomis R, Gribble FM, Altirriba J, Knuutila S, et al. (2007) Impairment of the ubiquitin-proteasome pathway is a downstream endoplasmic reticulum stress response induced by extracellular human islet amyloid polypeptide and contributes to pancreatic beta-cell apoptosis. Diabetes 56: 2284-2294. (Pubitemid 47358235)
18. Chang TL, Chang CJ, Lee WY, Lin MN, Huang YW, et al. (2009) The roles of ubiquitin and 26S proteasome in human obesity. Metabolism 58: 1643-1648.
19. Otoda T, Takamura T, Misu H, Ota T, Murata S, et al. (2013) Proteasome dysfunction mediates obesity-induced endoplasmic reticulum stress and insulin resistance in the liver. Diabetes 62: 811-824.
20. Queisser MA, Yao D, Geisler S, Hammes HP, Lochnit G, et al. (2010) Hyperglycemia impairs proteasome function by methylglyoxal. Diabetes 59: 670-678.
21. Kaniuk NA, Kiraly M, Bates H, Vranic M, Volchuk A, et al. (2007) Ubiquitinated-protein aggregates form in pancreatic beta-cells during diabetesinduced oxidative stress and are regulated by autophagy. Diabetes 56: 930-939. (Pubitemid 46525060)
22. Costes S, Huang CJ, Gurlo T, Daval M, Matveyenko AV, et al. (2011) beta-cell dysfunctional ERAD/ubiquitin/proteasome system in type 2 diabetes mediated by islet amyloid polypeptide-induced UCH-L1 deficiency. Diabetes 60: 227-238.
23. Bugliani M, Liechti R, Cheon H, Suleiman M, Marselli L, et al. (2013) Microarray analysis of isolated human islet transcriptome in type 2 diabetes and the role of the ubiquitin-proteasome system in pancreatic beta cell dysfunction. Mol Cell Endocrinol 367: 1-10.
24. Merglen A, Theander S, Rubi B, Chaffard G, Wollheim CB, et al. (2004) Glucose sensitivity and metabolism-secretion coupling studied during two-year continuous culture in INS-1E insulinoma cells. Endocrinology 145: 667-678. (Pubitemid 38183809)
25. Maestre I, Jordan J, Calvo S, Reig JA, Cena V, et al. (2003) Mitochondrial dysfunction is involved in apoptosis induced by serum withdrawal and fatty acids in the beta-cell line INS-1. Endocrinology 144: 335-345. (Pubitemid 36076123)
26. Longuet C, Broca C, Costes S, Hani EH, Bataille D, et al. (2005) Extracellularly regulated kinases 1/2 (p44/42 mitogen-activated protein kinases) phosphorylate synapsin I and regulate insulin secretion in the MIN6 beta-cell line and islets of Langerhans. Endocrinology 146: 643-654. (Pubitemid 40129820)
27. Tourrel C, Bailbe D, Lacorne M, Meile MJ, Kergoat M, et al. (2002) Persistent improvement of type 2 diabetes in the Goto-Kakizaki rat model by expansion of the beta-cell mass during the prediabetic period with glucagon-like peptide-1 or exendin-4. Diabetes 51: 1443-1452. (Pubitemid 34826610)
28. Ricordi C, Lacy PE, Finke EH, Olack BJ, Scharp DW (1988) Automated method for isolation of human pancreatic islets. Diabetes 37: 413-420. (Pubitemid 18096377)
29. Bucher P, Mathe Z, Morel P, Bosco D, Andres A, et al. (2005) Assessment of a novel two-component enzyme preparation for human islet isolation and transplantation. Transplantation 79: 91-97. (Pubitemid 40140006)
30. Poitout V, Amyot J, Semache M, Zarrouki B, Hagman D, et al. (2010) Glucolipotoxicity of the pancreatic beta cell. Biochim Biophys Acta 1801: 289-298.
31. Roccaro AM, Leleu X, Sacco A, Jia X, Melhem M, et al. (2008) Dual targeting of the proteasome regulates survival and homing in Waldenstrom macroglobulinemia. Blood 111: 4752-4763.
32. Miralles F, Portha B (2001) Early development of beta-cells is impaired in the GK rat model of type 2 diabetes. Diabetes 50 Suppl 1: S84-88.
33. Portha B, Giroix MH, Tourrel-Cuzin C, Le-Stunff H, Movassat J (2005) The GK Rat: A Prototype for the Study of Non-overweight Type 2 Diabetes. Methods Mol Biol 933: 125-159.
34. Kisselev AF, Akopian TN, Castillo V, Goldberg AL (1999) Proteasome active sites allosterically regulate each other, suggesting a cyclical bite-chew mechanism for protein breakdown. Mol Cell 4: 395-402. (Pubitemid 29499792)
35. Kloss A, Meiners S, Ludwig A, Dahlmann B (2010) Multiple cardiac proteasome subtypes differ in their susceptibility to proteasome inhibitors. Cardiovasc Res 85: 367-375.
36. Rodriguez KA, Edrey YH, Osmulski P, Gaczynska M, Buffenstein R (2012) Altered composition of liver proteasome assemblies contributes to enhanced proteasome activity in the exceptionally long-lived naked mole-rat. PLoS One 7: e35890.
37. An B, Goldfarb RH, Siman R, Dou QP (1998) Novel dipeptidyl proteasome inhibitors overcome Bcl-2 protective function and selectively accumulate the cyclin-dependent kinase inhibitor p27 and induce apoptosis in transformed, but not normal, human fibroblasts. Cell Death Differ 5: 1062-1075. (Pubitemid 29008220)
38. Wang H, Kouri G, Wollheim CB (2005) ER stress and SREBP-1 activation are implicated in beta-cell glucolipotoxicity. J Cell Sci 118: 3905-3915. (Pubitemid 41410274)
39. Tanaka Y, Tran PO, Harmon J, Robertson RP (2002) A role for glutathione peroxidase in protecting pancreatic beta cells against oxidative stress in a model of glucose toxicity. Proc Natl Acad Sci U S A 99: 12363-12368.
40. Maedler K, Sergeev P, Ris F, Oberholzer J, Joller-Jemelka HI, et al. (2002) Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J Clin Invest 110: 851-860.
41. Fribley A, Zeng Q, Wang CY (2004) Proteasome inhibitor PS-341 induces apoptosis through induction of endoplasmic reticulum stress-reactive oxygen species in head and neck squamous cell carcinoma cells. Mol Cell Biol 24: 9695-9704. (Pubitemid 39458799)
42. Uhal BD, Nguyen H, Dang M, Gopallawa I, Jiang J, et al. (2013) Abrogation of ER stress-induced apoptosis of alveolar epithelial cells by angiotensin 1-7. Am J Physiol Lung Cell Mol Physiol 305: L33-41.
43. Menendez-Benito V, Verhoef LG, Masucci MG, Dantuma NP (2005) Endoplasmic reticulum stress compromises the ubiquitin-proteasome system. Hum Mol Genet 14: 2787-2799. (Pubitemid 41418785)
44. Kitagawa H, Tani E, Ikemoto H, Ozaki I, Nakano A, et al. (1999) Proteasome inhibitors induce mitochondria-independent apoptosis in human glioma cells. FEBS Lett 443: 181-186. (Pubitemid 29078628)
45. Wu LW, Reid S, Ritchie A, Broxmeyer HE, Donner DB (1999) The proteasome regulates caspase-dependent and caspase-independent protease cascades during apoptosis of MO7e hematopoietic progenitor cells. Blood Cells Mol Dis 25: 20-29. (Pubitemid 29205487)
46. Bianchi G, Oliva L, Cascio P, Pengo N, Fontana F, et al. (2009) The proteasome load versus capacity balance determines apoptotic sensitivity of multiple myeloma cells to proteasome inhibition. Blood 113: 3040-3049.
47. Schmidt N, Alloway RR, Walsh RC, Sadaka B, Shields AR, et al. (2012) Prospective Evaluation of the Toxicity Profile of Proteasome Inhibitor-Based Therapy in Renal Transplant Candidates and Recipients. Transplantation 94: 352-361.
48. Asai M, Tsukamoto O, Minamino T, Asanuma H, Fujita M, et al. (2009) PKA rapidly enhances proteasome assembly and activity in in vivo canine hearts. J Mol Cell Cardiol 46: 452-462.
49. Zhang F, Hu Y, Huang P, Toleman CA, Paterson AJ, et al. (2007) Proteasome function is regulated by cyclic AMP-dependent protein kinase through phosphorylation of Rpt6. J Biol Chem 282: 22460-22471. (Pubitemid 47267329)